Physical activity in people with axial spondyloarthritis and the impact of overall attitudes, barriers, and facilitators: A cross-sectional study.

Musculoskeletal Care
Jens Ole RasmussenAnn Bremander

Abstract

To study the association between self-reported physical activity level and overall attitudes and barriers to and facilitators of physical activity in people with axial spondyloarthritis (axSpA), and to compare health status and quality of life (QoL) in people with different levels of physical activity. Four hundred forty-five members of the Danish Patient Association for Axial Spondyloarthritis completed an online survey including questions on physical activity, overall attitudes, barriers, and facilitators to physical activity, health, and QoL. Nonparametric tests and logistic regression analyses were performed. The response rate was 46%, median age 56 years (range 22-85), and 54% were men. In all, 23% reported low physical activity (physical activity ≥30 min on a moderate intensity level ≤1 day/week), 36% were moderately physically active (2-3 days/week), and 41% reported high physical activity (≥4 days/week). In a multivariate model, high physical activity was associated with a positive overall attitude ("physical activity is ok," OR 5.44, 95%CI [1.24, 23.87], and "I like physical activity," OR 14.22, 95%CI [3.34, 60.61]), and higher disagreement with barriers to physical activity, OR 1.12, 95%CI [1.07, 1.17]). People with m...Continue Reading

References

Apr 17, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A G E M de BoerM A G Sprangers
Feb 8, 2005·Arthritis and Rheumatism·Eva Eurenius, Christina H Stenström
Aug 3, 2006·International Journal of Occupational Medicine and Environmental Health·Dorota KaletaAnna Jegier
Jan 19, 2010·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Ryan E RhodesMark Conner
Mar 3, 2010·The Journal of Rheumatology·Laura A PassalentRobert D Inman
Apr 29, 2010·BMJ : British Medical Journal·Stephen RollnickBob Mash
Aug 5, 2010·Journal of Physical Activity & Health·Ester CerinNeville Owen
May 24, 2012·Journal of General Internal Medicine·Glyn ElwynMichael Barry
Jun 30, 2012·Arthritis Care & Research·Emma HaglundAnn Bremander
Jul 24, 2012·Lancet·Adrian E BaumanUNKNOWN Lancet Physical Activity Series Working Group
Jan 29, 2013·Seminars in Arthritis and Rheumatism·Sinead BrophyStefan Siebert
Jun 25, 2013·Medicine and Science in Sports and Exercise·Sindre M DyrstadSigmund A Anderssen
Nov 4, 2015·Journal of Physical Activity & Health·Tom O'DwyerFiona Wilson
May 14, 2016·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Rosemary McEachanMark Conner
Sep 26, 2016·Rheumatology International·Stéphanie FabreLaure Gossec
Jan 15, 2017·Annals of the Rheumatic Diseases·Désirée van der HeijdeJürgen Braun
Jan 24, 2017·Lancet·Joachim Sieper, Denis Poddubnyy
Jun 13, 2017·Advanced Biomedical Research·Seyde Shahrbanoo DanialiMohammad Mazaheri
Jul 13, 2018·Annals of the Rheumatic Diseases·Anne-Kathrin Rausch OsthoffTheodora P M Vliet Vlieland
Oct 17, 2018·Frontiers in Cardiovascular Medicine·Matthew A Nystoriak, Aruni Bhatnagar
Jun 21, 2019·Rheumatology·Sizheng Steven ZhaoNicola J Goodson
Jul 31, 2019·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Marta Kramer MikkelsenMary Jarden
Sep 19, 2019·Rheumatology Advances in Practice·Peter C RouseRaj Sengupta
Dec 6, 2019·Epidemiology and Health·Soudabeh YarmohammadiAli Ramezankhani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.